Latest News & Features
Europe
Biotech firm to ask Munich court to permanently lift injunction on CosMx products following ruling | Judgment comes a day after acquisition by Bruker was finalised. 9 May 2024
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/9666db60-0c8d-11ef-bb39-41d3e008b149-Gutman-Siegmund_Professional_Cropped%20(2).webp)
Careers
Star litigator moves firms with nearly a dozen attorneys | Biologic drug patent and Hatch-Waxman patent expert David Hanna also joins. 7 May 2024
Big Pharma
Asthma is one of the most common respiratory diseases in the US and the most common chronic disease among children | Israeli pharma giant’s suit comes amid allegations that it keeps life-saving prescriptions treatments artificially high. 7 May 2024
Americas
Two-day event in Boston brings together leading in-house patent counsel | Regeneron, USPTO, the Broad Institute and Novartis among attendees I Agenda includes the UPC, patent strategies, and multijurisdictional patent litigation | Registrations for LSPN Fall now open. 7 May 2024
Big Pharma
AstraZeneca, GSK and Teva among manufacturers accused of “improper” submission of patents | More than 300 patents targeted in second wave of challenges by Federal Trade Commission | ‘Junk patents’ block competition and ramp up prices unfairly, says FTC chair. 2 May 2024
Biotechnology
Ahead of her panel discussion at LSPN North America, BioNTech’s patent counsel, shares insights into her role and ensuring innovations meet the criteria of novelty and nonobviousness. 2 May 2024
Careers
Former senior legal advisor at USPTO brings wealth of life sciences experience | Move represents transition back into private practice after two decades. 2 May 2024
Biotechnology
Settlement comes after Acuitas alleged CureVac deliberately omitted its scientists as inventors on four US patents related to COVID-19 vaccines, claiming co-inventorship | Patents in suit relate to ongoing litigation with Pfizer and BioNTech. 30 April 2024
Biotechnology
Agreement clears the way for Sandoz to launch denosumab biosimilars in May 2025 | Dispute over multiple patents covering Prolia and Xgeva resolved. 30 April 2024
Americas
New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth “billions of dollars”, is filed as UK trial kicks off between Moderna, Pfizer and BioNTech. 26 April 2024